ACADIA Pharmaceuticals Inc (STU:DR6)
€ 17.155 0.785 (4.8%) Market Cap: 2.84 Bil Enterprise Value: 2.36 Bil PE Ratio: 23.42 PB Ratio: 5.26 GF Score: 73/100

ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 05:00PM GMT
Release Date Price: €16.03 (-0.41%)
Tessa Thomas Romero
JPMorgan Chase & Co, Research Division - Associate

Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tess Romero. I'm one of the biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and (inaudible) from the team.

Our next presenting company is ACADIA. And speaking on behalf of the company, we have CEO, Steve Davis. Before I turn it over to Steve, I just wanted to highlight that we do have a Q&A session after this formal presentation. There's an Ask A Question button in the portal for those that would like to submit in a question or we will have mic runners to take live questions as well.

So with that, I'm going to hand it over to Steve.

Stephen R. Davis
ACADIA Pharmaceuticals Inc. - CEO & Director

Great. Thanks so much, Tessa, and thanks to each of you for weathering the conditions getting over here, we had a little rise in the rain. So hopefully, you all made it over dry this morning, and thanks to each of you who are joining remotely.

I need to start with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot